IMUX FY 2018 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena

IMUXImmunic, Inc.

$138M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$15,000

Operating Income

-$42M

Net Income

-$41M

EPS (Diluted)

$-39.16

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$44M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$15M

Total Liabilities

$3M

Stockholders' Equity

$12M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$15,000	-$998,000	+98.5%
Operating Income	-$42M	-$53M	+20.2%
Net Income	-$41M	-$52M	+20.4%